Inotek Pharmaceuticals Corp (NASDAQ:ITEK): Phill Gross And Robert Atchinson’s Adage Capital Management filed an amended 13D.
You can check out Adage Capital Management’s latest holdings and filings here.
Please follow Adage Capital Management (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Adage Capital Management or update its stock holdings.
You can access the original SEC filing by clicking here.
Ownership Summary Table
|Name||Sole Voting Power||Shared Voting Power||Sole Dispositive Power||Shared Dispositive Power||Aggregate Amount Owned Power||Percent of Class|
|Adage Capital Partners||0||1,876,298||0||1,876,298||1,876,298||6.89%|
|Adage Capital Partners GP||0||1,876,298||0||1,876,298||1,876,298||6.89%|
|Adage Capital Advisors||0||1,876,298||0||1,876,298||1,876,298||6.89%|
Page 1 of 10 – SEC Filing
|SECURITIES AND EXCHANGE COMMISSION|
|Washington, D.C. 20549|
|Under the Securities Exchange Act of 1934|
|(Amendment No. 1)*|
|(Name of Issuer)|
|(Title of Class of Securities)|
|Adage Capital Partners GP, L.L.C.|
|200 Clarendon Street, 52nd Floor|
|Boston, MA 02116|
|(Name, Address and Telephone Number of Person|
|Authorized to Receive Notices and Communications)|
|(Date of Event Which Requires Filing of This Statement)|
If the filing person has previously filed a statement on Schedule
13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule
13d-1(f) or Rule 13d-1(g), check the following box. [ ]
(Page 1 of 10 Pages)
* The remainder of this cover page shall be filled out for a reporting
person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing
information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall
not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or
otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).